Kilitch Drugs (India) standalone net profit declines 36.71% in the December 2019 quarter

Explore Business Standard
Associate Sponsors
Co-sponsor

Sales decline 6.16% to Rs 18.14 crore
Net profit of Kilitch Drugs (India) declined 36.71% to Rs 2.19 crore in the quarter ended December 2019 as against Rs 3.46 crore during the previous quarter ended December 2018. Sales declined 6.16% to Rs 18.14 crore in the quarter ended December 2019 as against Rs 19.33 crore during the previous quarter ended December 2018. ParticularsQuarter EndedDec. 2019Dec. 2018% Var.Sales18.1419.33 -6 OPM %12.1323.33 -PBDT3.084.84 -36 PBT2.704.53 -40 NP2.193.46 -37Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
First Published: Feb 15 2020 | 11:00 AM IST